Gianluca Mazzoni

机构：Novo Nordisk (Denmark), University of Michigan, Ann Arbor Center for Independent Living · ORCID：0000-0003-2397-1064

发表论文 167 篇 · 总被引 3264 次 · h-index 29

代表论文

Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis (2025 · Nature Medicine · 被引 85)
The Cardioprotective Effects of Semaglutide Exceed Those of Dietary Weight Loss in Mice With HFpEF (2023 · JACC Basic to Translational Science · 被引 70)
Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits (2023 · Nature Communications · 被引 52)
LGR signaling mediates muscle-adipose tissue crosstalk and protects against diet-induced insulin resistance (2024 · Nature Communications · 被引 27)
Multi‐omics analysis reveals drivers of loss of β ‐cell function after newly diagnosed autoimmune type 1 diabetes: An INNODIA multicenter study (2024 · Diabetes/Metabolism Research and Reviews · 被引 14)
Circulating and hepatic levels of growth differentiation factor 15 in patients with metabolic dysfunction‐associated steatotic liver disease (2024 · Hepatology Research · 被引 11)